OB/GYN Clinical Alert – September 1, 2009
September 1, 2009
View Issues
-
Whole Blood in the Management of Hypovolemia Due to Obstetrical Hemorrhage
If I were asked to name the 4 most prominent clinical leaders in obstetrics in the United States during its formative years, they would be Hon, Quilligan, Zuspan (who, sadly, passed away in June), and Pritchard. -
Complications of Non-obstetric D&C
In a retrospective study of more than 5300 non-obstetric dilation and curettage (D&C) procedures between 1995 and 2006, these Austrian investigators found that the rate of intraoperative complications was only 1.9%. -
Antibiotics Added to Regimen for Medical Abortion
A large retrospective cohort time series compared strategies to prevent infectious complications of medical abortion at Planned Parenthood Federation of America (PPFA)-affiliated clinics. -
Explaining Poor Pregnancy Outcomes in Women with Celiac Disease
Celiac disease is associated with poor reproductive outcomes, particularly fetal growth restriction, but the mechanisms mediating this association are not understood. -
Incorporating Robotics in Gynecologic Oncology Training Programs
Robotic surgical procedures are increasingly being incorporating into the surgical management of gynecologic cancers, particularly early-stage endometrial and cervical cancer. -
Special Feature: Greetings, and Thanks to Leon Speroff
Several months ago, Leon asked whether I would take over the duties of editing OB/GYN Clinical Alert. I carefully considered this before agreeing. With so many sources of high-quality information available to clinicians, is OB/GYN Clinical Alert still relevant? What could I bring to ensure the high quality of the publication? -
Pharmacology Watch: Tamoxifen, SSRIs, and Breast Cancer Recurrence
n this issue: Tamoxifen and CYP2D6 inhibitors, FDA Actions, and FDA Warnings. -
Clinical Briefs in Primary Care supplement